Transcat, Inc (NASDAQ:TRNS) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.
On November 16, 2016, Transcat, Inc. (the Company) posted slides
to the Investor Relations section of its website that will
accompany the Companys presentations at the Southwest IDEAS
Investor Conference on November 16, 2016. The slides are attached
to this Form 8-K as Exhibit 99.1.
The information furnished to this Item 7.01, including Exhibit
99.1, shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act) or
otherwise subject to the liabilities under such section and shall
not be deemed to be incorporated by reference into any filing of
the Company under the Securities Act of 1933, as amended, or the
Exchange Act.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description | ||
| 99.1 |
Slides for November 16, 2016 Southwest IDEAS Investor Conference |
About Transcat, Inc (NASDAQ:TRNS)
Transcat, Inc. is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak). Through its Distribution segment, the Company markets, sells and rents national brand instruments to customers around the globe. The Company is focused on providing its services and products to the life science industries, which include pharmaceutical, biotechnology, medical device manufacturing and other Food and Drug Administration (FDA)-regulated businesses. Transcat, Inc (NASDAQ:TRNS) Recent Trading Information
Transcat, Inc (NASDAQ:TRNS) closed its last trading session 00.00 at 10.30 with 2,757 shares trading hands.
